Nov 3, 2026 · California Workers' Compensation Institute
ONE CHEAP PAIN PILL DRIVES CALIFORNIA WORKERS' COMP DRUG SPENDING
The generic anti-inflammatory meloxicam has become the biggest source of anti-inflammatory drug spending in California workers' compensation, rising from 1.7 percent of the group's spending in 2020 to 30.8 percent in 2025, according to the California Workers' Compensation Institute. The average payment per prescription climbed from $9 in 2020 to $92 in 2025, even though the median payment was still under $14. The gap comes from four high-cost capsule products that made up only 12.6 percent of meloxicam prescriptions but 75.7 percent of the payments, a pattern the institute says warrants close attention from payers and prescribers.